The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study

• Fernanda Borges da Silva,
• Lorena Lobo de Figueiredo-Pontes,
• Maria Isabel Ayrosa Madeira,
• Luisa Corrêa de Araujo Koury,
• Ana Silvia Gouvêa de Lima,
• Priscila Santos Scheucher,
• Juan Luiz Coelho-Silva,
• Katia Borgia Barbosa Pagnano,
• Ronald Pallota,
• Maria de Lourdes Chauffaille,
• Marcos Roberto Pedron Oltramari,
• Rosane Isabel Bittencourt,
• Marcia Higashi,
• Rodrigo Miguel Bendlin,
• Elvira Deolinda Rodrigues Pereira Velloso,
• Bob Lowenberg,
• Arnold Ganser,
• Nancy Berliner,
• Peter Valk,
• Eduardo Magalhães Rego,
• Fabiola Traina

Affiliations

Fernanda Borges da Silva

Division of Hematology, Department of Medicine, Ribeirão Preto Medical School; Center for Cell-Based Therapy, São Paulo, SP, Brazil

Lorena Lobo de Figueiredo-Pontes

Division of Hematology, Department of Medicine, Ribeirão Preto Medical School; Center for Cell-Based Therapy, São Paulo, SP, Brazil

Maria Isabel Ayrosa Madeira

Division of Hematology, Department of Medicine, Ribeirão Preto Medical School; Center for Cell-Based Therapy, São Paulo, SP, Brazil

Luisa Corrêa de Araujo Koury

Division of Hematology, Department of Medicine, Ribeirão Preto Medical School; Center for Cell-Based Therapy, São Paulo, SP, Brazil

Ana Silvia Gouvêa de Lima

Division of Hematology, Department of Medicine, Ribeirão Preto Medical School; Center for Cell-Based Therapy, São Paulo, SP, Brazil

Priscila Santos Scheucher

Division of Hematology, Department of Medicine, Ribeirão Preto Medical School; Center for Cell-Based Therapy, São Paulo, SP, Brazil

Juan Luiz Coelho-Silva

Division of Hematology, Department of Medicine, Ribeirão Preto Medical School; Center for Cell-Based Therapy, São Paulo, SP, Brazil

Katia Borgia Barbosa Pagnano

University of Campinas/Hemocentro-Unicamp, Campinas, São Paulo, SP, Brazil

Ronald Pallota

ABC Medical School, São Paulo, SP, Brazil

Maria de Lourdes Chauffaille

Hematology Division, Federal University of Sao Paulo, São Paulo, SP, Brazil

Marcos Roberto Pedron Oltramari

Bone Marrow Transplant Center, Hospital de Base, São José do Rio Preto, SP, Brazil

Rosane Isabel Bittencourt

Hematology Division, University Hospital of the Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil

Marcia Higashi

Amaral Carvalho Hospital, Jaú, SP, Brazil

Rodrigo Miguel Bendlin

Hematology Division, University Hospital of the Federal University of Paraná, Curitiba, PR, Brazil

Elvira Deolinda Rodrigues Pereira Velloso

Department of Hematology, Clinical Hospital at University of São Paulo, São Paulo, SP, Brazil; Cytogenetics Laboratory, Israelita Albert Einstein Hospital, São Paulo, SP, Brazil

Bob Lowenberg

Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands

Arnold Ganser

Department of Hematology, Hannover Medical School, Hannover, Germany

Nancy Berliner

Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Peter Valk

Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands

Eduardo Magalhães Rego

Division of Hematology, Department of Medicine, Ribeirão Preto Medical School; Center for Cell-Based Therapy, São Paulo, SP, Brazil

Fabiola Traina

Division of Hematology, Department of Medicine, Ribeirão Preto Medical School; Center for Cell-Based Therapy, São Paulo, SP, Brazil; Fabiola Traina, Division of Hematology, Department of Medicine, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil, and Center for Cell-Based Therapy, University of São Paulo, Ribeirão Preto, SP, Brazil